Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Rises By 17.0%
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 40,600 shares, a growth o
PLX, PLBY and THMO Among Mid-day Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersJaguar Health (NASDAQ:JAGX) stock rose 6215.8% to $5.35 during Monday's regular session. The current volume of 532.2K shares is 6.8% of Jaguar Health's average full-day volume over the last 100
Avalo Therapeutics Completes Target Enrollment in Phase 2 PEAK Trial
Avalo Announces It Has Completed Targeted Enrollment of 80 Patients in Phase 2 PEAK Trial of AVTX-002 in Non-Eosinophilic Asthma
Topline data expected in the second quarter of 2023 WAYNE, Pa. and ROCKVILLE, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX), today announced that it completed enrollment of the 80
Looking Into Avalo Therapeutics's Return On Capital Employed
According to Benzinga Pro, during Q3, Avalo Therapeutics (NASDAQ:AVTX) earned $3.19 million, a 124.58% increase from the preceding quarter. Avalo Therapeutics also posted a total of $14.95 million in
Avalo Therapeutics, Inc. to Post Q4 2022 Earnings of ($0.55) Per Share, Jefferies Financial Group Forecasts (NASDAQ:AVTX)
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) – Equities researchers at Jefferies Financial Group lowered their Q4 2022 EPS estimates for Avalo Therapeutics in a research note issued to inves
Oppenheimer Lowers Avalo Therapeutics (NASDAQ:AVTX) Price Target to $10.00
Avalo Therapeutics (NASDAQ:AVTX – Get Rating) had its price objective decreased by investment analysts at Oppenheimer to $10.00 in a research note issued on Tuesday, Stock Target Advisor reports. Op
Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Decreases By 27.5%
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) saw a significant decline in short interest during the month of October. As of October 31st, there was short interest totalling 35,300 shares, a d
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Significant Drop in Short Interest
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Rating) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 3
Loading...
No Stock Yet